Dermata Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.775 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.12M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.